all AI news
Poolbeg Pharma identifies new flu drug targets using AI
June 29, 2023, 2:51 p.m. | Vish Gain
Silicon RepublicSilicon Republic www.siliconrepublic.com
Using an AI platform developed by CytoReason, London-headquartered Poolbeg Pharma has been analysing flu human challenge trials data since March 2022.
Read more: Poolbeg Pharma identifies new flu drug targets using AI
ai ai platform challenge data health healthcare human innovation london medicine pharma platform
More from www.siliconrepublic.com / Silicon RepublicSilicon Republic
Jobs in AI, ML, Big Data
Data Engineer
@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania
Artificial Intelligence – Bioinformatic Expert
@ University of Texas Medical Branch | Galveston, TX
Lead Developer (AI)
@ Cere Network | San Francisco, US
Research Engineer
@ Allora Labs | Remote
Ecosystem Manager
@ Allora Labs | Remote
Founding AI Engineer, Agents
@ Occam AI | New York